Audible Bleeding team Matt Chia (@chia_md) and Gowri Gowda (@GowriGowda11) are joined by the co-principle investigators of the BEST-CLI trial, Dr. Matthew Menard and Dr. Alik Farber. We talk about the results of BEST-CLI, marking what is sure to be the next landmark trial in vascular surgery. Drs. Menard and Farber give their insights on being clinical trialists and surgeons in the modern era, reflecting on challenges in conducting this work and its broad-reaching
Drs Alik Farber and Matthew Menard join us to discuss Best Endovascular vs. best Surgical Therapy in patients with Critical Limb Ischemia (BEST-CLI), a prospective, multicenter, randomized, open-label (two-arm), comparison to evaluate the effectiveness of best surgical to best endovascular revascularization in patients with CLI.